| 2025年中报 | 2024年年报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 临床合理用药系统(元) | 88,608,508.43 | 181,414,554.14 | 176,987,464.87 | 87,522,400.00 |
| 软件开发和技术服务(元) | 1,282,777.67 | 4,147,972.58 | 6,129,964.76 | 1,788,800.00 |
| 数据更新和运维服务(元) | 31,203,012.00 | 59,780,491.59 | 51,094,374.58 | 23,365,300.00 |
| 营业成本(元) | ||||
| 临床合理用药系统(元) | 11,247,378.95 | 21,410,127.64 | 22,058,920.94 | 10,980,800.00 |
| 软件开发和技术服务(元) | 1,268,394.60 | 4,090,232.38 | 4,037,189.03 | 1,320,000.00 |
| 数据更新和运维服务(元) | 12,033,714.33 | 24,483,103.48 | 19,537,574.59 | 9,396,600.00 |
| 毛利(元) | ||||
| 临床合理用药系统(元) | 77,361,129.48 | 160,004,426.50 | 154,928,543.93 | 76,541,600.00 |
| 软件开发和技术服务(元) | 14,383.07 | 57,740.20 | 2,092,775.73 | 468,800.00 |
| 数据更新和运维服务(元) | 19,169,297.67 | 35,297,388.11 | 31,556,799.99 | 13,968,700.00 |
| 毛利率(%) | ||||
| 临床合理用药系统(%) | 87.31 | 88.20 | 87.54 | 87.45 |
| 软件开发和技术服务(%) | 1.12 | 1.39 | 34.14 | 26.21 |
| 数据更新和运维服务(%) | 61.43 | 59.04 | 61.76 | 59.78 |
| 收入构成(%) | ||||
| 临床合理用药系统(%) | 73.17 | 73.94 | 75.57 | 77.68 |
| 软件开发和技术服务(%) | 1.06 | 1.69 | 2.62 | 1.59 |
| 数据更新和运维服务(%) | 25.77 | 24.37 | 21.82 | 20.74 |
| 毛利构成(%) | ||||
| 临床合理用药系统(%) | 80.13 | 81.90 | 82.16 | 84.13 |
| 软件开发和技术服务(%) | 0.01 | 0.03 | 1.11 | 0.52 |
| 数据更新和运维服务(%) | 19.86 | 18.07 | 16.73 | 15.35 |